NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.10
-0.15 (-1.05%)
At close: Sep 16, 2026, 4:00 PM EDT
14.10
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $483.97 million as of September 16, 2026. Its market cap has increased by 48.98% in one year.
Market Cap
483.97M
Enterprise Value
502.20M
1-Year Change
48.98%
Ranking
Category
Stock Price
$14.10
ChartMarket Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $483.97M, an increase of 23.06%. That is a compound annual growth rate of 3.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 483.97M | -5.89% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cytek Biosciences | 627.82M |
| OrthoPediatrics | 583.29M |
| Delcath Systems | 570.45M |
| BrainsWay | 543.88M |
| Cerus | 513.89M |
| Tactile Systems Technology | 511.26M |
| Senseonics Holdings | 467.41M |
| Sight Sciences | 447.87M |